Offstream
news

Georgia receives 43,200 doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.
2021-07-10

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

India officially approves the emergency use of AstraZeneca and University of Oxford's AZD1222 vaccine, which is to be manufactured locally by the Serum Institute of India, as well as Bharat Biotech's BBV152 vaccine.
2021-01-3

India approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca, becoming the third country in the world to do so after the United Kingdom and Argentina.
2021-01-1

The United Kingdom approves a vaccine made by the University of Oxford and AstraZeneca for use in the country. Health Secretary Matt Hancock says that the rollout of this vaccine will begin on January 4.
2020-12-30

Argentina approves a vaccine made by the University of Oxford and AstraZeneca for use in the country, becoming the second country after the UK to approve this vaccine.
2020-12-30

El Salvador approves a vaccine made by the University of Oxford and AstraZeneca for use in the country.
2020-12-30

AstraZeneca begins Phase III clinical trials of its potential COVID-19 vaccine, AZD1222, which it developed with the University of Oxford, to some 30,000 adults in the United States.
2020-08-31